Arch Pediatr Adolesc Med
October 2002
Background: Based on limited anecdotal evidence, glucagon is used for the management of intractable neonatal hypoglycemia persisting in the face of high glucose administration rates.
Objective: To evaluate the short-term response of blood glucose levels to an intravenous infusion of glucagon.
Design: A retrospective observational study in which all newborns who received glucagon infusions (usual dose, 0.